TrialAnnals of the rheumatic diseases2015

Sarilumab for the treatment of ankylosing spondylitis: results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN).

Joachim Sieper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.